Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
London doctors on verge of defeating HIV thanks to new programme

London doctors believe they could be on course to defeat HIV after a dramatic fall in the number of new infections, the Standard can reveal. An early intervention programme imported from San Francisco has seen a 42 per cent reduction in new cases of HIV at 56 Dean Street in Soho, the biggest sexual health clinic in Europe.

Published
11 January 2017
From
London Evening Standard
Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research

Gilead Sciences, Inc. today announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects. These projects will be conducted by leading academic institutions, non-profit organizations and community groups from around the world, focusing on three key areas: translational research, efficacy studies in animal models and community perspectives of HIV cure.

Published
10 January 2017
From
Gilead press release
The Success Of HIV Treatment Is Increasing The Risk Of Drug-Resistance

Global health agencies are succeeding in getting more people with HIV on antiretroviral therapy, a combination of drugs that suppress the virus to undetectable levels in the blood and reduce the risk of transmission to another person. But scientists are beginning to detect a disturbing new trend: The rise of drug-resistant HIV strains, especially in countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa.

Published
04 January 2017
From
Huffington Post
Gates Foundation to Invest Up to $140 Million in HIV Prevention Device

The tiny implantable drug pump is being developed by Intarcia Therapeutics Inc. It can hold six or 12 months’ supply of medicine and is designed to deliver microdoses continuously to patients, ensuring they stay on the treatment.

Published
30 December 2016
From
Wall Street Journal
Virologic failure detected in a quarter of ART-treated children in Tanzania

A quarter of children and adolescents in Tanzania taking antiretroviral therapy (ART) have major resistance to one or more anti-HIV drug, investigators report in AIDS. In 86%

Published
28 December 2016
By
Michael Carter
The UK’s largest sexual health clinic saw a 40% drop in new HIV infections this year

The clinic at 56 Dean Street in Soho, central London, the largest sexual health clinic in the UK, saw an unprecedented 40% drop in new HIV diagnoses

Published
22 December 2016
By
Gus Cairns
In the era of universal treatment, what are HIV clinical guidelines for?

The purpose and structure of clinical HIV guidelines may have to change radically now that universal treatment on diagnosis is the clinical consensus, physicians from the European

Published
22 December 2016
By
Gus Cairns
How close are we to a cure for HIV? A Q&A with HIV cure scientific superstars

What’s going on in HIV cure research? Is it ethical to take people off of HIV antiretrovirals if they participate in HIV cure research? These were some of the questions that lead researchers who are part of the amfAR Institute for HIV Cure Research at UCSF tackled at a forum on World AIDS Day this year.

Published
22 December 2016
From
BETA blog
British team studies initiation of treatment shortly after HIV diagnosis

A team of researchers in London, England, has reviewed the medical records of 113 men whose acute HIV infection was diagnosed at a sexual health clinic. The team found that most of the men (77%) initiated ART at their first clinic visit. Furthermore, they found that 99% of participants had an undetectable viral load within six months of initiating ART.

Published
21 December 2016
From
CATIE
GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

GlaxoSmithKline PLC’s ViiV Healthcare announced positive phase-three trial results for its new HIV drug in a dual-drug regimen, supporting the company’s audacious bet that it can shift the treatment orthodoxy away from three-drug combinations.

Published
20 December 2016
From
Wall Street Journal

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.